Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and TAAs. More
Dendritic cell (DC) generation and manipulation technology for the development of a cancer vaccine and rheumatoid arthritis (RA) therapeutics. Based on DC manipulating technology, Creagene is developing DC-based cancer vaccines against renal cell car More
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and tumor associated antigens (TAAs). More
Different myeloma tumor cell lines and their expansion for use in drug screening and research More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 26 pages - $125
Dec 2010 - 19 pages - $99
Mar 2011 - 120 pages - $3,500
May 2011 - 7 pages - $500
Aug 2009 - $15,200
Aug 2010 - $15,200
Oct 2010 - 64 pages - $2,000
Dec 2010 - 29 pages - $1,000
Feb 2011 - 27 pages - $125
Oct 2010 - 66 pages - $1,000
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us